BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 23, 2000
View Archived Issues
NIH grant for acute lung injury research goes to CollaGenex
Read More
Interferon Sciences acquires option to purchase 50% of Metacine stock
Read More
Oncophage enters phase II sarcoma study; trial marks drug's seventh cancer indication
Read More
Lilly terminates (R)-fluoxetine license agreement with Sepracor
Read More
TroVax colorectal cancer vaccine approved for phase I/II
Read More
FDA grants priority review status for pulmonary hypertension NDA
Read More
Celebrex introduced in major European market
Read More
Interim data from AIDS dementia complex trial of CPI-1189 announced
Read More
DuPont designs novel template-constrained cyclic peptide somatostatin analogues
Read More
Active enantiomers of new thiourea NNRTIs effective against resistant HIV strains
Read More
Long-acting subdermal contraceptive implant now available in Germany
Read More
Antitumor activity and mechanism of action of new Hsp90 inhibitor examined in preclinical studies
Read More
Encouraging data reported for Emitasol in diabetic gastroparesis
Read More
G207 studied further for anticancer, antimetastatic potential
Read More
Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion
Read More
Coley begins phase II trials with CpG compound
Read More
SmithKline Beecham exercises development option for HGS compound
Read More
MDR-reversing pyripyropene characterized at Japanese Cancer Association meeting
Read More
SkyePharma's Solaraze earns FDA approval
Read More
Orally active plant-derived peptide with hypoglycemic activity
Read More
Vivus withdraws Alibra NDA
Read More
Novel anthracyclines designed by Menarini display excellent antitumor activity
Read More
Italian scientists discover antitumor agents particularly useful in colon cancer
Read More
Sankyo's new therapeutics for Alzheimer's disease display dual actions
Read More
NK1 receptor antagonists useful for CNS disorders reported by Roche
Read More
Pharmacia identifies new herpesvirus polymerase inhibitors
Read More
Imidazole-based H3 receptor antagonists and their use patented by Schering-Plough
Read More